Document is current

Any future updates will be listed below

PI3K/AKT/mTOR pathway is activated after imatinib secondary resistance in gastrointestinal stromal tumors (GISTs)

Crossref DOI link: https://doi.org/10.1007/s12032-015-0554-6

Published Online: 2015-03-11

Published Print: 2015-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark